Anti-cancer peptide-based therapeutic strategies in solid tumors

Cell Mol Biol Lett. 2022 Apr 9;27(1):33. doi: 10.1186/s11658-022-00332-w.

Abstract

Background: Nowadays, conventional medical treatments such as surgery, radiotherapy, and chemotherapy cannot cure all types of cancer. A promising approach to treat solid tumors is the use of tumor-targeting peptides to deliver drugs or active agents selectively.

Result: Introducing beneficial therapeutic approaches, such as therapeutic peptides and their varied methods of action against tumor cells, can aid researchers in the discovery of novel peptides for cancer treatment. The biomedical applications of therapeutic peptides are highly interesting. These peptides, owing to their high selectivity, specificity, small dimensions, high biocompatibility, and easy modification, provide good opportunities for targeted drug delivery. In recent years, peptides have shown considerable promise as therapeutics or targeting ligands in cancer research and nanotechnology.

Conclusion: This study reviews a variety of therapeutic peptides and targeting ligands in cancer therapy. Initially, three types of tumor-homing and cell-penetrating peptides (CPPs) are described, and then their applications in breast, glioma, colorectal, and melanoma cancer research are discussed.

Keywords: Drug delivery; Peptide-based strategies; Targeted delivery; Tumor-homing peptides.

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Cell-Penetrating Peptides* / pharmacology
  • Cell-Penetrating Peptides* / therapeutic use
  • Drug Delivery Systems / methods
  • Glioma* / drug therapy
  • Humans
  • Ligands
  • Neoplasms* / drug therapy

Substances

  • Antineoplastic Agents
  • Cell-Penetrating Peptides
  • Ligands